Long-term outcomes in patients with ipilimumab-naive advanced melanoma in the phase 3 Keynote-006 study who completed pembrolizumab treatment.
Journal article published in 2017 by
M. Carlino 
,
H. Zhou,
C. Robert,
G. Long,
J. Schachter,
A. Arance,
J. Grob,
MLotem,
L. Mortier,
Paul C. Lorigan,
A. Daud,
B. Neyns,
C. McNeil,
C. Blank,
T. Petrella
and other authors.
,
H. Zhou,
C. Robert,
G. Long,
J. Schachter,
A. Arance,
J. Grob,
MLotem,
L. Mortier,
Paul C. Lorigan,
A. Daud,
B. Neyns,
C. McNeil,
C. Blank,
T. Petrella
and other authors.
